Clinical Trial Update: Quetiapine Fumarate Bipolar Maintenance Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial of quetiapine fumarate as maintenance monotherapy for bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Quetiapine fumarate (Quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED